Investigations on the effect of caffeine on cerebral venous vessel contrast by using susceptibility-weighted imaging (SWI) at 1.5, 3 and 7 T

NeuroImage

Volumn 40, Issue 1, 2008, Pages 11-18

  Sedlacik, Jan ^a   Helm, Katharina ^a   Rauscher, Alexander ^a,b   Stadler, Jörg ^c   Mentzel, Hans Joachim ^a   Reichenbach, Jürgen R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE;

ADULT; ARTICLE; BLOOD OXYGENATION; BRAIN BLOOD FLOW; BRAIN VEIN; CONTROL GROUP; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; NEUROIMAGING; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STUDENT T TEST; WHITE MATTER;

ADULT; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL VEINS; CEREBRAL VENTRICLES; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN;

EID: 38949096757     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2007.11.046     Document Type: Article

References (30)

1. Barth M., and Norris D.G. Very high-resolution three-dimensional functional MRI of the human visual cortex with elimination of large venous vessels. NMR Biomed. 20 5 (2007) 477-484
2. Behzadi Y., and Liu T.T. Caffeine reduces the initial dip in the visual BOLD response at 3 T. NeuroImage 32 1 (2006) 9-15
3. 2 reactivity testing. J. Clin. Neurosci. 14 5 (2007) 464-467
4. Cameron O.G., Modell J.G., and Hariharan M. Caffeine and human cerebral blood flow: a positron emission tomography study. Life Sci. 47 13 (1990) 1141-1146
5. Dager S.R., Layton M.E., Strauss W., Richards T.L., Heide A., Friedman S.D., Artru A.A., Hayes C.E., and Posse S. Human brain metabolic response to caffeine and the effects of tolerance. Am. J. Psychiatry 156 2 (1999) 229-237
6. Essig M., Reichenbach J.R., Schad L.R., Schoenberg S.O., Debus J., and Kaiser W.A. High-resolution MR venography of cerebral arteriovenous malformations. Magn. Reson. Imaging 17 10 (1999) 1417-1425
7. Field A.S., Laurienti P.J., Yen Y.F., Burdette J.H., and Moody D.M. Dietary caffeine consumption and withdrawal: confounding variables in quantitative cerebral perfusion studies?. Radiology 227 1 (2003) 129-135
8. Fredholm B.B., Bättig K., Holmén J., Nehlig A., and Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51 1 (1999) 83-133
9. Ge Y., Haacke E., and Grossman R. Susceptibility weighted imaging (SWI) of cerebral blood oxygenation during voluntary hyperventilation and apnea. Proc. Intl. Soc. Magn. Reson. Med. 15 (2007) 2300
10. Haacke E., Hu C., Parrish T., and Xu Y. Whole brain stress test using caffeine: effects on fMRI and SWI at 3 T. Proc. Int. Soc. Magn. Reson. Med. 11 (2003) 1731
11. Haacke E.M., Xu Y., Cheng Y.C., and Reichenbach J.R. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 52 3 (2004) 612-618
12. Hermier M., and Nighoghossian N. Contribution of susceptibility-weighted imaging to acute stroke assessment. Stroke 35 8 (2004) 1989-1994
13. Kaufmann A.M., Firlik A.D., Fukui M.B., Wechsler L.R., Jungries C.A., and Yonas H. Ischemic core and penumbra in human stroke. Stroke 30 1 (1999) 93-99
14. Laurienti P.J., Field A.S., Burdette J.H., Maldjian J.A., Yen Y.F., and Moody D.M. Relationship between caffeine-induced changes in resting cerebral perfusion and blood oxygenation level-dependent signal. AJNR Am. J. Neuroradiol. 24 8 (2003) 1607-1611
15. Liu T.T., Behzadi Y., Restom K., Uludag K., Lu K., Buracas G.T., Dubowitz D.J., and Buxton R.B. Caffeine alters the temporal dynamics of the visual BOLD response. NeuroImage 23 4 (2004) 1402-1413
16. Lunt M.J., Ragab S., Birch A.A., Schley D., and Jenkinson D.F. Comparison of caffeine-induced changes in cerebral blood flow and middle cerebral artery blood velocity shows that caffeine reduces middle cerebral artery diameter. Physiol. Meas. 25 2 (2004) 467-474
17. Meno J.R., Nguyen T.S., Jensen E.M., Alexander West G., Groysman L., Kung D.K., Ngai A.C., Britz G.W., and Winn H.R. Effect of caffeine on cerebral blood flow response to somatosensory stimulation. J. Cereb. Blood Flow Metab. 25 6 (2005) 775-784
18. Mulderink T.A., Gitelman D.R., Mesulam M.M., and Parrish T.B. On the use of caffeine as a contrast booster for BOLD fMRI studies. NeuroImage 15 1 (2002) 37-44
19. Nehlig A., Daval J.L., and Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Brain Res. Rev. 17 2 (1992) 139-170
20. Norris D.G. Principles of magnetic resonance assessment of brain function. J. Magn. Reson. Imaging 23 6 (2006) 794-807
21. 2A receptors. Trends Pharmacol. Sci. 17 10 (1996) 364-372
22. Rauscher A., Sedlacik J., Barth M., Haacke E.M., and Reichenbach J.R. Noninvasive assessment of vascular architecture and function during modulated blood oxygenation using susceptibility weighted magnetic resonance imaging. Magn. Reson. Med. 54 1 (2005) 87-95
23. Reichenbach J.R., and Haacke E.M. High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed. 14 7-8 (2001) 453-467
24. Reichenbach J.R., Venkatesan R., Schillinger D.J., Kido D.K., and Haacke E.M. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 204 1 (1997) 272-277
25. Rorden C., and Brett M. Stereotaxic display of brain lesions. Behav. Neurol. 12 4 (2000) 191-200
26. Sehgal V., Delproposto Z., Haacke E.M., Tong K.A., Wycliffe N., Kido D.K., Xu Y., Neelavalli J., Haddar D., and Reichenbach J.R. Clinical applications of neuroimaging with susceptibility-weighted imaging. J. Magn. Reson. Imaging 22 4 (2005) 439-450
27. Tan I.L., van Schijndel R.A., Pouwels P.J., van Walderveen M.A., Reichenbach J.R., Manoliu R.A., and Barkhof F. MR venography of multiple sclerosis. AJNR Am. J. Neuroradiol. 21 6 (2000) 1039-1042
28. Urso R., Blardi P., and Giorgi G. A short introduction to pharmacokinetics. Eur. Rev. Med. Pharmacol. Sci. 6 2-3 (2002) 33-44
29. Woods R.P., Grafton S.T., Holmes C.J., Cherry S.R., and Mazziotta J.C. Automated image registration: I. General methods and intrasubject, intramodality validation. J. Comput. Assist. Tomogr. 22 1 (1998) 139-152
30. Xu Y., and Haacke E.M. The role of voxel aspect ratio in determining apparent vascular phase behavior in susceptibility weighted imaging. Magn. Reson. Imaging 24 2 (2006) 155-160